NYSE · Software - Infrastructure · USD
Oracle Corporation (ORCL) Stock Analysis
Oracle Corporation (ORCL) is a Software - Infrastructure stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
ORCL Key Statistics
As of Oct 21, 2026Trading
- Open
- $133.12
- Previous Close
- $131.14
- Day's Range
- 127.70–133.40
- 52-Week Range
- 114.50–287.19
- Volume
- 26.13M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 1.77
Valuation
- Market Cap
- $391.46B
- P/E Ratio
- 20.24
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 11.74
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 0.74
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 5.45
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 6.38
Financials (FY)
- Revenue (FY)
- $67.36B+17.35%
- Net Income (FY)
- $17.09B+37.32%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 26.36%
- Shares Outstanding
- 3.03B
- 1-Year Return
- −52.44%
Dividend and dates
- Dividend
- $2.00+1.53%
- Ex-Dividend Date
- October 9, 2026
- Earnings Date
- December 14, 2026
- Avg Volume
- 30.13M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, ORCL closed at $129.13, −52.44% over 1 year.
Oracle Corporation (ORCL) has a market capitalization of $391.46B.
In fiscal 2025, ORCL reported revenue of $67.36B.
ORCL Stock Return by Calendar Year
Oracle Corporation (ORCL) 10-year return: what $10,000 became
- 1 year
- $10,000 $4,756
- −52.44%
- 5 years
- $10,000 $14,347
- +43.47%
- 10 years
- $10,000 $39,519
- +295.19%
If you had invested $10,000 in Oracle Corporation (ORCL) 10 years ago, at the close on October 21, 2016, it would have been worth $39,519 at the close on October 21, 2026: +295.19% in total, +14.73% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −32.86% |
| 2025 | +18.13% |
| 2024 | +59.99% |
| 2023 | +30.94% |
| 2022 | −4.65% |
| 2021 | +36.89% |
| 2020 | +24.25% |
| 2019 | +19.34% |
| 2018 | −2.97% |
| 2017 | +24.94% |
| 2016 (partial year) | −6.57% |
As of October 21, 2026.
ORCL Revenue and Earnings by Fiscal Year
FY ends May| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $67.36B | $17.09B | 25.4% |
| 2024 | $57.40B | $12.44B | 21.7% |
| 2023 | $52.96B | $10.47B | 19.8% |
| 2022 | $49.95B | $8.50B | 17.0% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $67.36B | $44.34B | $22.44B | $17.09B | 25.4% |
| 2024 | $57.40B | $40.47B | $18.05B | $12.44B | 21.7% |
| 2023 | $52.96B | $37.82B | $16.07B | $10.47B | 19.8% |
| 2022 | $49.95B | $36.39B | $13.77B | $8.50B | 17.0% |
Annual figures as reported, in the company's reporting currency. As of May 31, 2026.
ORCL Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $2.00 | 4 | — |
| 2025 | $1.90 | 4 | +18.7% |
| 2024 | $1.60 | 4 | +5.3% |
| 2023 | $1.52 | 4 | +18.8% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $2.00 | 4 | — |
| 2025 | $1.90 | 4 | +18.7% |
| 2024 | $1.60 | 4 | +5.3% |
| 2023 | $1.52 | 4 | +18.8% |
| 2022 | $1.28 | 4 | +6.7% |
| 2021 | $1.20 | 4 | +25.0% |
| 2020 | $0.96 | 4 | +5.5% |
| 2019 | $0.91 | 4 | +19.7% |
| 2018 | $0.76 | 4 | +5.6% |
| 2017 | $0.72 | 4 | — |
Most recent payment: $0.50 per share, ex-dividend October 9, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
ORCL Valuation vs Software - Infrastructure Median
Median of 182 stocks| Metric | ORCL | Software - Infrastructure median | vs median |
|---|---|---|---|
| P/E | 20.24 | 30.17 | 33% below |
| P/S ratio | 5.45 | 3.27 | 67% above |
| Profit margin | 26.36% | 2.53% | 23.8 pts above |
Medians across 182 Software - Infrastructure stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Oracle AI Agent Studio for Industry Applications Helps Accelerate Business Outcomes
YahooAstraZeneca and Oracle collaborate to test AI in clinical trial recruitment
clinicaltrialsarena.comMarket Chatter: Oracle Chairman Larry Ellison Borrowed Billions to Finance Son's Warner Bros. Discovery Acquisition
YahooVertex (VERX) Could Be 17% Undervalued As Oracle Win Fuels Interest
YahooBloom Energy vs. Oracle: Which AI Infrastructure Stock Is the Better Buy After the Jupiter Setback?
The Motley FoolOracle Calls Force Majeure Already?
The Motley Fool
All 20 articles ↓Show fewer ↑
Oracle Is Winning In AI, But It's Still Overvalued
SeekingAlphaOracle Just Dropped 12% in a Month. Is It Time to Sell, or Load Up?
TIKROracle (ORCL) Expands Its AI Healthcare Push With A New Drugmaker Partnership
YahooWhat Is Oracle’s (ORCL) Economic Moat, and Is It Widening or Narrowing?
YahooOracle (ORCL): Can Rival Clouds Become Its Best Database Sales Channel?
YahooCoreWeave Falls 4% as HSBC Reiterates Bearish Call on Debt Risk; Nebius Drops 5%, Oracle Holds Steady
24/7 Wall St.Oracle Bonds Face Downgrade Risks As AI Trade Fizzles Across Tech Sector
TIKROracle, AstraZeneca Explore AI To Tackle Clinical-Trial Recruitment Challenge
StocktwitsAstraZeneca and Oracle Launch AI Partnership to Improve Clinical Trials and Patient Care
InvestorsHubStellar Cyber Security Operations Solutions Now Available on Oracle Marketplace
YahooAstraZeneca Partners With Oracle to Refine Clinical Research With AI
The Wall Street JournalOracle Joins Forces With AstraZeneca to Put AI to Work in Drug Research
BenzingaMicrosoft vs. Oracle: Which Tech Stock Is a Better Buy in 2026?
The Motley FoolOracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Software - Infrastructure Stocks
Microsoft Corporation
$3.96T
PLTRPalantir Technologies Inc.
$484.74B
PANWPalo Alto Networks, Inc.
$284.05B
CRWDCrowdStrike Holdings, Inc.
$245.07B
FTNTFortinet, Inc.
$127.70B
NETCloudflare, Inc.
$109.39B
Popular Technology Stocks
NVIDIA Corporation
$5.36T
AAPLApple Inc.
$5.02T
TSMTaiwan Semiconductor Manufacturing Company Limited
$2.24T
AVGOBroadcom Inc.
$1.61T
SKHYSK hynix Inc.
$1.04T















